Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
43%(3 trials)

Phase Distribution

Ph phase_2
4
57%
Ph phase_1
2
29%
Ph phase_3
1
14%

Phase Distribution

2

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
4(57.1%)
Phase 3Large-scale testing
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(7)

Detailed Status

Completed7

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (28.6%)
Phase 24 (57.1%)
Phase 31 (14.3%)

Trials by Status

completed7100%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_3

Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis

NCT03931915
completedphase_1

A Study of TAK-385 in Hormone Treatment-naïve Participants With Prostate Cancer

NCT02141659
completedphase_2

Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer

NCT02135445
completedphase_1

A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects

NCT02093390
completedphase_2

A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis

NCT01452685
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT03931915Phase 3

Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis

Completed
NCT02141659Phase 1

A Study of TAK-385 in Hormone Treatment-naïve Participants With Prostate Cancer

Completed
NCT02135445Phase 2

Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer

Completed
NCT02093390Phase 1

A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects

Completed
NCT01452685Phase 2

A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis

Completed
NCT01458301Phase 2

Efficacy and Safety of TAK-385 in the Treatment of Endometriosis

Completed
NCT01452659Phase 2

Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7